South Korea Lumasiran Market (2025-2031) | Value, Forecast, Analysis, Size & Revenue, Industry, Growth, Share, Segmentation, Trends, Outlook, Competitive Landscape, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Lumasiran Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Lumasiran Market - Industry Life Cycle

3.4 South Korea Lumasiran Market - Porter's Five Forces

3.5 South Korea Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 South Korea Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 South Korea Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F

3.8 South Korea Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 South Korea Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 South Korea Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about rare diseases and the need for innovative treatments like lumasiran.

4.2.2 Favorable government initiatives and policies supporting the development and adoption of advanced therapies.

4.2.3 Growing research and development activities leading to the introduction of new treatment options in the market.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval and commercialization of novel therapeutic products.

4.3.2 High cost associated with lumasiran treatment limiting accessibility for a broader patient population.

4.3.3 Competition from existing treatment options and potential future entrants in the market.

6.1 South Korea Lumasiran Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 South Korea Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 South Korea Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F

6.1.4 South Korea Lumasiran Market Revenues & Volume, By others, 2021- 2031F

6.2 South Korea Lumasiran Market, By Application

6.2.1 Overview and Analysis

6.2.2 South Korea Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F

6.2.3 South Korea Lumasiran Market Revenues & Volume, By Others, 2021- 2031F

6.3 South Korea Lumasiran Market, By Dosage form

6.3.1 Overview and Analysis

6.3.2 South Korea Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F

6.3.3 South Korea Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F

6.4 South Korea Lumasiran Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 South Korea Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.3 South Korea Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F

6.4.4 South Korea Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F

6.4.5 South Korea Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F

6.5 South Korea Lumasiran Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 South Korea Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F

6.5.3 South Korea Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.4 South Korea Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F

6.6 South Korea Lumasiran Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 South Korea Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 South Korea Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 South Korea Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 South Korea Lumasiran Market Export to Major Countries

7.2 South Korea Lumasiran Market Imports from Major Countries

8.1 Patient enrollment in clinical trials for lumasiran.

8.2 Adoption rate of lumasiran among healthcare providers.

8.3 Patient satisfaction and quality of life improvement post-lumasiran treatment.

9.1 South Korea Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 South Korea Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 South Korea Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F

9.4 South Korea Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 South Korea Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 South Korea Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 South Korea Lumasiran Market Revenue Share, By Companies, 2024

10.2 South Korea Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters